On Feb. 8, 2022, Moderna announced a new supply agreement with the government of Colombia for 10.8 million doses of Moderna’s COVID-19 vaccine. These doses were in addition to 10 million doses supplied to Colombia in 2021. Under the terms of the agreement, Moderna expected to deliver one million doses in the first quarter of 2022, six million doses in the second quarter of 2022, and 3.8 million doses in the third quarter of 2022.

In Latin America, Moderna had announced a supply agreement with the government of Chile for two million doses of Moderna’s COVID-19 booster vaccine or an updated booster vaccine candidate, if authorized. Under the terms of the agreement, Moderna expected to start delivering doses in February 2022, pending obtaining local emergency use authorization.